Brief: SciBase Study Shows Nevisense Potential For Assessment Of Skin Barrier

SciBase Holding AB (publ)

12/04/2021 07:06

April 12 (Reuters) - SciBase Holding AB (publ)  SCIB.ST :
    * NEW CLINICAL STUDY SHOWS NEVISENSE POTENTIAL FOR
ASSESSMENT OF
SKIN BARRIER AND ATOPIC DERMATITIS
    * ANNOUNCED PUBLICATION OF A NEW CLINICAL STUDY SUPPORTING
ITS
STRATEGY TO DEVELOP MULTIPLE CLINICAL APPLICATIONS FOR NEVISENSE
AND NEVISENSE GO PLATFORMS
    * STUDY IS FROM SWISS INSTITUTE OF ALLERGY AND ASTHMA
RESEARCH
(SIAF)
    * IN STUDY NEVISENSE WAS USED TO ASSESS SKIN BARRIER OF
PATIENTS
WITH ATOPIC DERMATITIS (AD) AND COULD ACCURATELY DETECT SIGNS OF
ATOPIC DERMATITIS EVEN ON UNAFFECTED SKIN
    * NEVISENSE MEASUREMENT ALSO CORRELATED WITH RELEVANT
BIOMARKERS
FOR ATOPIC DERMATITIS

Source text for Eikon:  ID:nWkr10G6rW 
Further company coverage:  SCIB.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))